Roche's Tecentriq receives positive opinion from EU medicines agency

ZURICH (Reuters) - A European Medicines Agency (EMA) panel said on Friday it has recommended Roche's immunotherapy Tecentriq as a treatment for advanced bladder and lung cancer, setting the stage for European Commission approval this year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news